This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionNext revisionBoth sides next revision | ||
home:mp:stages [12.14.2018] – [Stage 2: Unhealthy VDR, pathogens downregulate immune activity] sallieq | home:mp:stages [12.14.2018] – [Stage 4: Benicar and 1,25-D are fully successful at activating the VDR] sallieq | ||
---|---|---|---|
Line 24: | Line 24: | ||
- | =====Stage 3: Benicar | + | ===== Olmesartan Medoxomil |
The Marshall Protocol (MP) is designed to interrupt the inflammatory disease process. The most important medication Marshall Protocol patients take is not the low doses of antibiotics, | The Marshall Protocol (MP) is designed to interrupt the inflammatory disease process. The most important medication Marshall Protocol patients take is not the low doses of antibiotics, | ||
Line 33: | Line 33: | ||
It should be noted that Benicar has a second action, that of an anti-inflammatory. That is why many patients report feeling //better// when taking Benicar. | It should be noted that Benicar has a second action, that of an anti-inflammatory. That is why many patients report feeling //better// when taking Benicar. | ||
- | =====Stage 4: Benicar | + | ===== Continuing treatment, Olmesartan Medoxomil |
In Stage 4, the combination of Benicar and 1,25-D is entirely successful at displacing bacterial proteins such as Capnine. Patients would be able to slow their immune response by withdrawing Benicar. Choosing to do so, however, would reduce its anti-inflammatory, | In Stage 4, the combination of Benicar and 1,25-D is entirely successful at displacing bacterial proteins such as Capnine. Patients would be able to slow their immune response by withdrawing Benicar. Choosing to do so, however, would reduce its anti-inflammatory, |